Luo Gaoxing, Falta Edward M, Elster Eric A
Radiation and Combat Injury Department/Code 33, Combat Casualty Care Directorate, Naval Medical Research Center, Silver Spring, MD 20910-6500, USA.
Curr Diab Rep. 2005 Aug;5(4):305-10. doi: 10.1007/s11892-005-0028-x.
Although steroids have been the cornerstone of immunosuppressive regimens to treat and prevent rejection in organ transplantation, the past decade has seen many successful attempts to minimize or eliminate steroid use. This has been undertaken to decrease the diverse side effects seen with chronic steroid treatment. These efforts have focused on both steroid avoidance and complete elimination, and have been successful across broad patient groups. The key to these efforts has been the adoption of induction protocols with either lymphocyte-depleting agents or anti-interleukin-2 strategies, coupled with the use of the newer maintenance immunosuppressants. In this review, we address the feasibility and benefits of steroid-free and steroid avoidance protocols in kidney, pancreas, liver, and heart transplantation.
尽管类固醇一直是器官移植中治疗和预防排斥反应的免疫抑制方案的基石,但在过去十年中,人们进行了许多成功的尝试,以尽量减少或消除类固醇的使用。这样做是为了减少长期使用类固醇治疗所出现的各种副作用。这些努力既着眼于避免使用类固醇,也致力于完全消除类固醇,并且在广泛的患者群体中取得了成功。这些努力的关键在于采用淋巴细胞清除剂或抗白细胞介素-2策略的诱导方案,同时使用新型维持性免疫抑制剂。在本综述中,我们探讨了在肾脏、胰腺、肝脏和心脏移植中无类固醇和避免使用类固醇方案的可行性及益处。